Medical Properties Trust, Inc. (NYSE:MPW) Receives $5.50 Consensus Target Price from Brokerages

Shares of Medical Properties Trust, Inc. (NYSE:MPW) have been assigned an average recommendation of “Hold” from the nine analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $5.50.

Several brokerages have commented on MPW. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price on the stock in a research note on Friday, September 13th. Truist Financial upped their target price on shares of Medical Properties Trust from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, September 13th. Finally, Wolfe Research raised shares of Medical Properties Trust to a “hold” rating in a report on Monday, September 23rd.

Medical Properties Trust Price Performance

Shares of NYSE MPW opened at $4.21 on Friday. The company has a debt-to-equity ratio of 1.69, a quick ratio of 2.93 and a current ratio of 2.38. The company has a 50 day simple moving average of $5.14 and a two-hundred day simple moving average of $4.92. Medical Properties Trust has a fifty-two week low of $2.92 and a fifty-two week high of $6.55. The company has a market capitalization of $2.53 billion, a price-to-earnings ratio of -1.00, a P/E/G ratio of 0.66 and a beta of 1.32.

Medical Properties Trust Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Monday, September 9th were given a $0.08 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 7.60%. Medical Properties Trust’s payout ratio is currently -7.58%.

Insider Activity

In related news, Director C Reynolds Thompson III sold 20,530 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. This trade represents a 27.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elizabeth N. Pitman acquired 8,087 shares of Medical Properties Trust stock in a transaction on Wednesday, September 18th. The shares were bought at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the purchase, the director now directly owns 76,740 shares of the company’s stock, valued at $461,207.40. The trade was a 11.78 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.53% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in MPW. Vanguard Group Inc. lifted its stake in shares of Medical Properties Trust by 8.2% during the 1st quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock worth $437,373,000 after purchasing an additional 7,084,981 shares during the last quarter. Silver Point Capital L.P. boosted its stake in Medical Properties Trust by 155.3% in the third quarter. Silver Point Capital L.P. now owns 6,000,000 shares of the real estate investment trust’s stock valued at $35,100,000 after acquiring an additional 3,650,000 shares in the last quarter. Goldentree Asset Management LP purchased a new stake in shares of Medical Properties Trust during the 1st quarter valued at $15,966,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Medical Properties Trust by 353.5% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust’s stock worth $20,625,000 after buying an additional 2,748,245 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Medical Properties Trust by 22.6% in the second quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock valued at $29,775,000 after buying an additional 1,274,481 shares during the last quarter. 71.79% of the stock is currently owned by institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.